Øyvind Kongstun Arnesen is appointed new chairman at Oslo Cancer Cluster (OCC).
On a recent General Assembly, Oslo Cancer Cluster elected Øyvind Kongstun Arnesen as new chairman after a unanimous vote. He takes over after Henrik Lund who opted not to stand for re-election after four years in the position.
Øyvind is currently CEO at Ultimovacs, a member of Oslo Cancer Cluster with its own cancer vaccine technology. Read more about Ultimovacs here.
— We look forward to having Øyvind as our chairman. He is very knowledgeable and enthusiastically committed to oncology research and development. His medical background combined with biotech entrepreneurship and years in the pharmaceutical industry, will help elevate Oslo Cancer Cluster to the next level, says General Manager of Oslo Cancer Cluster Ketil Widerberg.
Thank You Henrik
Oslo Cancer Cluster thanks Henrik Lund for his four years chairman and many years on the board. Oslo Cancer Cluster has during his years as chairman grown both at home and internationally. Widerberg thanked Henrik for his commitment to OCC during his tenure:
— Thank you for your commitment to Oslo Cancer Cluster all these years. During your time as chairman we have undergone important changes, and now have a solid foundation to build upon. The goal is to be the leading European center of cancer innovation.